Unknown

Dataset Information

0

Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients.


ABSTRACT: Epidermolysis bullosa simplex (EBS) is a blistering skin disease caused by dominant-negative mutations in either KRT5 or KRT14, resulting in impairment of keratin filament structure and epidermal fragility. Currently, nearly 200 mutations distributed across the entire length of these genes are known to cause EBS. Genome editing using programmable nucleases enables the development of ex vivo gene therapies for dominant-negative genetic diseases. A clinically feasible strategy involves the disruption of the mutant allele while leaving the wild-type allele unaffected. Our aim was to develop a traceless approach to efficiently disrupt KRT5 alleles using TALENs displaying unbiased monoallelic disruption events and devise a strategy that allows for subsequent screening and isolation of correctly modified keratinocyte clones without the need for selection markers. Here we report on TALENs that efficiently disrupt the KRT5 locus in immortalized patient-derived EBS keratinocytes. Inactivation of the mutant allele using a TALEN working at sub-optimal levels resulted in restoration of intermediate filament architecture. This approach can be used for the functional inactivation of any mutant keratin allele regardless of the position of the mutation within the gene and is furthermore applicable to the treatment of other inherited skin disorders.

SUBMITTER: Aushev M 

PROVIDER: S-EPMC5527154 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients.

Aushev Magomet M   Koller Ulrich U   Mussolino Claudio C   Cathomen Toni T   Reichelt Julia J  

Molecular therapy. Methods & clinical development 20170705


Epidermolysis bullosa simplex (EBS) is a blistering skin disease caused by dominant-negative mutations in either <i>KRT5</i> or <i>KRT14</i>, resulting in impairment of keratin filament structure and epidermal fragility. Currently, nearly 200 mutations distributed across the entire length of these genes are known to cause EBS. Genome editing using programmable nucleases enables the development of ex vivo gene therapies for dominant-negative genetic diseases. A clinically feasible strategy involv  ...[more]

Similar Datasets

| S-EPMC2956915 | biostudies-literature
| S-EPMC4519992 | biostudies-literature
2012-03-10 | E-GEOD-36406 | biostudies-arrayexpress
| S-EPMC2195993 | biostudies-literature
2012-03-10 | GSE36406 | GEO
| S-EPMC8624175 | biostudies-literature
| S-EPMC4665702 | biostudies-literature
2023-12-06 | GSE246345 | GEO
| S-EPMC4847350 | biostudies-literature
| S-EPMC5014520 | biostudies-literature